Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder

OBJECTIVE: Mazindol has been proposed as a potential treatment of children with attention deficit/hyperactivity disorder (ADHD). The purpose of this pilot study was to assess its pharmacokinetics, short-term efficacy, and safety. SUBJECTS AND METHODS: A total of 24 children (aged 9–12 years) with AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Konofal, Eric, Zhao, Wei, Laouénan, Cédric, Lecendreux, Michel, Kaguelidou, Florentia, Benadjaoud, Lila, Mentré, France, Jacqz-Aigrain, Evelyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266272/
https://www.ncbi.nlm.nih.gov/pubmed/25525331
http://dx.doi.org/10.2147/DDDT.S65495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266272/
https://www.ncbi.nlm.nih.gov/pubmed/25525331
http://dx.doi.org/10.2147/DDDT.S65495

Ejemplares similares